Lacutamab Chemical Properties

form 

Liquid

color 

Colorless to light yellow

Lacutamab Usage And Synthesis

Uses

Lacutamab (IPH4102) is a humanizedized monoclonal antibody (mAb) directed against the immune receptor molecule KIR3DL2, produced by recombinant technology in CHO cells. Lacutamab can be used in research of cutaneous T-cell lymphoma[1].

References

[1] Van Der Weyden C, et, al. IPH4102, a monoclonal antibody directed against the immune receptor molecule KIR3DL2, for the treatment of cutaneous T-cell lymphoma. Expert Opin Investig Drugs. 2018 Aug;27(8):691-697. DOI:10.1080/13543784.2018.1498081

Lacutamab(2187368-16-5)Related Product Information

• Bedinvetmab
• Firivumab
• Dectrekumab
• Crenezumab
• Romilkimab
• Duligotuzumab
• Anselamimab
• Ginisortamab
• Vepsitamab
• Nofazinlimab